NDAINJECTIONINJECTABLE
Approved
Jan 1947
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Tubocurarine chloride is a non-depolarizing neuromuscular blocking agent administered by injection used during anesthesia to facilitate intubation and surgical relaxation. It works by competitively blocking acetylcholine at the neuromuscular junction, preventing muscle contraction. This agent has been a foundational anesthetic adjunct since its FDA approval in 1947.
LOE Approaching
This legacy anesthetic is approaching loss of exclusivity with minimal current commercial investment; brand team focus is likely maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This legacy product offers minimal career growth opportunities and is associated with maintenance-mode commercial operations at Pfizer. Roles linked to tubocurarine typically involve managing declining market share and ensuring continuity for residual demand rather than driving expansion or innovation.
Brand Manager (Specialty/Legacy)Medical Science Liaison
Worked on TUBOCURARINE CHLORIDE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.